These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 8139609

  • 1. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
    van Hilten JJ, van der Zwan AD, Zwinderman AH, Roos RA.
    Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
    [Abstract] [Full Text] [Related]

  • 2. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I, Parkinson Study Group.
    Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
    [Abstract] [Full Text] [Related]

  • 3. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.
    Richards M, Marder K, Cote L, Mayeux R.
    Mov Disord; 1994 Jan; 9(1):89-91. PubMed ID: 8139610
    [Abstract] [Full Text] [Related]

  • 4. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E, Franchignoni F, Pasetti C, Ferriero G, Picco D.
    Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
    Rabey JM, Bass H, Bonuccelli U, Brooks D, Klotz P, Korczyn AD, Kraus P, Martinez-Martin P, Morrish P, Van Sauten W, Van Hilten B.
    Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
    [Abstract] [Full Text] [Related]

  • 6. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
    Louis ED, Lynch T, Marder K, Fahn S.
    Mov Disord; 1996 Mar; 11(2):185-92. PubMed ID: 8684390
    [Abstract] [Full Text] [Related]

  • 7. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
    Martínez-Martín P, Gil-Nagel A, Gracia LM, Gómez JB, Martínez-Sarriés J, Bermejo F.
    Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
    [Abstract] [Full Text] [Related]

  • 8. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT, Goetz CG.
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [Abstract] [Full Text] [Related]

  • 9. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P, Oakes D, Cui L.
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [Abstract] [Full Text] [Related]

  • 10. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, Poewe W, Wenning GK.
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [Abstract] [Full Text] [Related]

  • 11. Does the ADL part of the unified Parkinson's disease rating scale measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation.
    Hariz GM, Lindberg M, Hariz MI, Bergenheim AT.
    Mov Disord; 2003 Apr; 18(4):373-81. PubMed ID: 12671942
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Minimal clinically important change on the unified Parkinson's disease rating scale.
    Schrag A, Sampaio C, Counsell N, Poewe W.
    Mov Disord; 2006 Aug; 21(8):1200-7. PubMed ID: 16673410
    [Abstract] [Full Text] [Related]

  • 14. Responsiveness of impairments and disabilities in Parkinson's disease.
    Visser M, Marinus J, Stiggelbout AM, van Hilten JJ.
    Parkinsonism Relat Disord; 2006 Jun; 12(5):314-8. PubMed ID: 16621658
    [Abstract] [Full Text] [Related]

  • 15. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD).
    Martínez-Martín P, Forjaz MJ, Cubo E, Frades B, de Pedro Cuesta J, ELEP Project Members.
    Mov Disord; 2006 Feb; 21(2):208-14. PubMed ID: 16161158
    [Abstract] [Full Text] [Related]

  • 16. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.
    Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ.
    Mov Disord; 2002 Sep; 17(5):867-76. PubMed ID: 12360535
    [Abstract] [Full Text] [Related]

  • 17. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.
    Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, Chmura TA, Ahlskog JE, Dorflinger EE.
    Mov Disord; 1994 Jul; 9(4):390-4. PubMed ID: 7969204
    [Abstract] [Full Text] [Related]

  • 18. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB.
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [Abstract] [Full Text] [Related]

  • 19. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
    Post B, Merkus MP, de Bie RM, de Haan RJ, Speelman JD.
    Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
    [Abstract] [Full Text] [Related]

  • 20. Using the Internet to assess activities of daily living and hand function in people with Parkinson's disease.
    Hoffmann T, Russell T, Thompson L, Vincent A, Nelson M.
    NeuroRehabilitation; 2008 Dec; 23(3):253-61. PubMed ID: 18560142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.